BTLA and cancer: While it is well known that lymphocytes in cancer microenvironments also tend to exhibit an exhausted phenotype [34–36], which manifests in part in the co-expression of several distinct coinhibitory receptors including PD-1, BTLA, and 2B4, the systemic immune changes that occur as a result of malignancy and their impact on immune responses during infection have not been well characterized.